Abstract
D&MD's High Content Screening (HCS): An Industry Analysis is focused on an emerging and key segment of the life science tools and technology space-high content analysis. High content biology has various ramifications in life science research, academic research, drug discovery, and development. This report focuses on this emerging space, the major technologies and products, and its market landscape through both a qualitative and quantitative analysis. In addition to describing the technical aspects of high-content screening (HCS) in this report, we present a thorough market analysis complemented by primary data from a proprietary survey conducted on this topic by D&MD.
HCS and secondary screening are an outgrowth of high-throughput screening that have commanded much attention and resources in the pharmaceutical and biotechnology companies over the past decade. Currently, the challenge has moved towards analyses of sub-cellular organization, morphology, and these are major facets of HCS.
Table of Contents
Chapter 1: Executive Summary
- Scope of this Report
- Why is HCS Attractive?
- Market Definition and Applications
Chapter 2: Product/Application Segmentation and Offerings for the
High-Content Screening/Analysis (HCS/HCA) Marketplace
- Classes of Biological Measurements Possible with HCS/HCA
- Instrumentation Platforms for High-Content Screening/Analysis (HCS/HCA)
- Reagent/Assay Offerings for the HCS/HCA Space
Chapter 3: Market Analysis of High-Content Screening:
Qualitative and Quantitative
- Current Applications of High-Content Screening/Analysis and the
- Breakout of High-Content Assays by Biological Pathway Interrogated
- Opportunities and Challenges for Market Adoption of High-Content
- Screening/Analysis
- Challenges for Market Adoption
- Current Market Size, Segmentation, and Growth Rate of the Total
- Screening Marketplace in Pharma and Biotech
- Current Market Size, Segmentation, and Growth Rates of HCS/HCA
- Summary
- Market Shares and Growth Rates of the Key Participants in the
- HCS/HCA Space
Appendix I: High-Content Screening and Analysis: An End-user
Survey of Pharmaceutical & Academic Scientist
Appendix II: High-Content Screening and Analysis:
Landscape and Trends
Appendix III: Glossary of Terms
